Isatuximab
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and extracellular enzyme CD38 in malignant cells of the hematological system, a highly expressed protein in multiple myeloma. It exhibits antitumor activity, antibody-dependent cytotoxicity, complement-dependent cytotoxicity, and antibody-dependent cytophagocytosis, directly inducing apoptosis without crosslinking. Isatuximab inhibits CD38 extracellular enzyme activity, affecting various cellular functions.
Product Specifications
CAS Number
1461640-62-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
145.21 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Apoptosis | CD38
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
